Gallbladder Cancer Clinical Trials in Shanghai
2 recruitingShanghai, China
Showing 1–2 of 2 trials
Recruiting
Phase 1
Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer
Gallbladder CancerBiliary Tract NeoplasmsCholangiocarcinoma, Intrahepatic+2 more
Shanghai Zhongshan Hospital18 enrolled1 locationNCT07614061
Recruiting
Phase 2
Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer
Gallbladder CancerInitially Unresectablethe First Line Treatment
Lu Wang, MD, PhD50 enrolled1 locationNCT05757336